Glomerular disease augments kidney accumulation of synthetic anionic polymers

  • Alexander N. Prossnitz
  • , Gary W. Liu
  • , Diana G. Eng
  • , Yilong Cheng
  • , Jeffrey W. Pippin
  • , Robert J. Lamm
  • , Chayanon Ngambenjawong
  • , Stuart J. Shankland
  • , Suzie H. Pun

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

2 Scopus citations

Abstract

Statement of Purpose: Chronic kidney disease (CKD) affects over 30 million Americans. The majority of drugs that treat podocyte disease are administered systemically and have broad side effects. Since polymer-drug conjugates can alter the biodistribution and pharmokinetics of drug cargoes, we sought to elucidate the polymer properties that enhance in vivo kidney accumulation to enable new technologies to treat CKD.

Original languageEnglish
Title of host publicationSociety for Biomaterials Annual Meeting and Exposition 2019
Subtitle of host publicationThe Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting
PublisherSociety for Biomaterials
Pages504
Number of pages1
ISBN (Electronic)9781510883901
DOIs
StatePublished - 2019
Event42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Seattle, United States
Duration: 3 Apr 20196 Apr 2019

Publication series

NameTransactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium
Volume40
ISSN (Print)1526-7547

Conference

Conference42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence
Country/TerritoryUnited States
CitySeattle
Period3/04/196/04/19

Fingerprint

Dive into the research topics of 'Glomerular disease augments kidney accumulation of synthetic anionic polymers'. Together they form a unique fingerprint.

Cite this